Bessemer Group Inc. lowered its stake in shares of Analogic Co. (NASDAQ:ALOG) by 24.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 16,800 shares of the medical research company’s stock after selling 5,400 shares during the quarter. Bessemer Group Inc. owned approximately 0.13% of Analogic worth $1,407,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Flinton Capital Management LLC grew its position in Analogic by 100.0% during the second quarter. Flinton Capital Management LLC now owns 1,768 shares of the medical research company’s stock valued at $129,000 after buying an additional 884 shares during the period. State Board of Administration of Florida Retirement System bought a new position in Analogic during the third quarter valued at about $224,000. Piedmont Investment Advisors LLC bought a new position in Analogic during the third quarter valued at about $227,000. Crossmark Global Holdings Inc. bought a new position in Analogic during the third quarter valued at about $250,000. Finally, Cigna Investments Inc. New bought a new position in Analogic during the fourth quarter valued at about $483,000. Institutional investors own 94.07% of the company’s stock.
A number of equities analysts have weighed in on the stock. BidaskClub lowered shares of Analogic from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. Jefferies Group reiterated a “hold” rating and set a $80.00 target price on shares of Analogic in a research report on Friday, December 8th. Finally, Zacks Investment Research lowered shares of Analogic from a “buy” rating to a “hold” rating in a research report on Wednesday, January 31st.
Analogic Co. (NASDAQ ALOG) opened at $79.60 on Wednesday. The firm has a market cap of $1,001.90, a PE ratio of 41.15, a price-to-earnings-growth ratio of 4.01 and a beta of 0.82. Analogic Co. has a 1 year low of $66.00 and a 1 year high of $89.50.
Analogic (NASDAQ:ALOG) last issued its earnings results on Wednesday, December 6th. The medical research company reported $0.75 earnings per share for the quarter, topping analysts’ consensus estimates of $0.43 by $0.32. Analogic had a negative net margin of 15.06% and a positive return on equity of 5.09%. The firm had revenue of $106.90 million during the quarter, compared to analyst estimates of $100.55 million. During the same quarter last year, the business earned $0.43 earnings per share. The company’s quarterly revenue was down 11.7% on a year-over-year basis. equities analysts expect that Analogic Co. will post 2.86 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/14/bessemer-group-inc-reduces-stake-in-analogic-co-alog.html.
Analogic Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.